
Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 22, 2023, titled "VENUS REMEDIES BAGS APPROVAL TO MARKET MEROPENEM, ITS BLOCKBUSTER GENERIC DRUG, IN SPAIN".
Filed with NSE ·

Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 22, 2023, titled "VENUS REMEDIES BAGS APPROVAL TO MARKET MEROPENEM, ITS BLOCKBUSTER GENERIC DRUG, IN SPAIN".
6ix hasn’t read this filing yet.
Follow Venus Remedies into a list and get an email when it puts out news.
Follow Venus Remedies